Nynomic's non-contact measurement technology is benefiting from megatrends in growth markets. The main sales driver is industry (clean tech, 65%), followed by agriculture (21%) and life science (14%). Whether measuring nutrient content in the soil while driving a tractor, coating wafers in semiconductor production or quality control of tablets - Nynomic sensors ensure precision.
Over the last ten years, turnover has risen by an average of 12% per year and EBIT by as much as 25%. But 2024 was different: customers postponed orders worth up to EUR 15 million until 2025. While sales in Q1 still climbed by 6.5% (which was weak for the company), they slumped by 20% in each of the following two quarters. "But nothing has completely collapsed. The trends are intact," emphasized CEO Maik Müller in an interview at the Munich Capital Market Conference. According to Peters, high-margin business with pharmaceuticals and semiconductors in particular was postponed, which had a negative impact on EBIT (Q1: +7%; Q2: -16%; Q3: -75%). Nevertheless, Nynomic remains on the offensive: "Our 200 R&D employees are working flat out on new projects," says Peters, who has managed the company together with Müller since it was founded in 1995.
I had set a buy limit of 39.50 after the recent announcement of the cooperation with Novattis and actually got my money's worth. I had already sold the share at €4 (then still m-u-t) but unfortunately much too early.
